Loupakis, Fotios
3trees Healthcare,
Italy
2025 Rank: 100016
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 3038 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 100016 | 107056 |
| Total Cites | 1712 | 1867 |
| H-index | 17 | 17 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 185 | 206 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 238 | 263 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1281 | 1373 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.36 |
| Self-Citation Percentage |
8.30%
|
|
Loupakis, Fotios
Istituto Oncologico Veneto IOV - IRCCS,
Italy
2024 Rank: 92417
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 3055 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 92417 | 90760 |
| Total Cites | 1622 | 1810 |
| H-index | 18 | 19 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 176 | 196 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 245 | 275 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1241 | 1334 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.36 |
| Self-Citation Percentage |
10.39%
|
|
Loupakis, Fotios
Istituto Oncologico Veneto IOV - IRCCS,
Italy
2023 Rank: 77761
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2820 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 77761 | 80592 |
| Total Cites | 1786 | 2002 |
| H-index | 18 | 19 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 214 | 245 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 276 | 317 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1322 | 1398 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.43 |
| Self-Citation Percentage |
10.79%
|
|
Loupakis, Fotios
Istituto Oncologico Veneto IOV - IRCCS,
Italy
2022 Rank: 70691
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2701 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 70691 | 68763 |
| Total Cites | 1772 | 2024 |
| H-index | 18 | 20 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 234 | 268 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 295 | 342 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1372 | 1495 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.35 |
| Self-Citation Percentage |
12.45%
|
|
Loupakis, Fotios
Istituto Oncologico Veneto IOV - IRCCS,
Italy
2021 Rank: 71368
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2592 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 71368 | 71337 |
| Total Cites | 2575 | 2920 |
| H-index | 23 | 25 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 35 | 35 |
| Total Cites to Single+First Authored Papers | 363 | 422 |
| Number of Single+First+Last Authored Papers | 54 | 54 |
| Total Cites to Single+First+Last Authored Papers | 451 | 521 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 1989 | 2145 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.36 |
| Self-Citation Percentage |
11.82%
|
|
Loupakis, Fotios
Istituto Oncologico Veneto IOV - IRCCS,
Italy
2020 Rank: 76455
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2684 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 76455 | 80550 |
| Total Cites | 1536 | 1732 |
| H-index | 18 | 19 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 272 | 308 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 336 | 378 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1194 | 1287 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.35 |
| Self-Citation Percentage |
11.32%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.